Godsland IF, Walton C, Felton C, et al. Insulin resistance, secretion, and metabolism in users of oral contraceptives. J Clin Endocrinol Metab 1992;74:64–70.
101.
Ettinger B, Golditch IM. Medroxyprogesterone acetate for the evaluation of hypertestosteronism in hirsute women. Fertil Steril 1977;28:1285–1288.
102.
Jeppsson S, Gershagen S, Johansson ED, et al. Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent. Acta Endocrinol (Copenh) 1982;99:339–343.
103.
Gordon GG, Southern AL, Calanog A, et al. The effect of medroxyprogesterone acetate on androgen metabolism in the polycystic ovary syndrome. J Clin Endocrinol Metab 1972,35:444–447.
104.
Meldrum DR, Chang RJ, Lu J, et al. “Medical oophorectomy” using a long-acting GNRH agonist—a possible new approach to the treatment of endometriosis. J Clin Endocrinol Metab 1982;54:1081– 1083.
105.
Falsetti L, Pasinetti E. Treatment of moderate and severe hirsutism by gonadotropin-releasing hormone agonists in women with polycystic ovary syndrome and idiopathic hirsutism. Fertil Steril 1994;61:817–822.
106.
Morcos RN, Abdul-Malak ME, Shikora E. Treatment of hirsutism with a gonadotropin-releasing hormone agonist and estrogen replacement therapy. Fertil Steril 1994;61:427–431.
107.
Tiitinen A, Simberg N, Stenman UH, et al. Estrogen replacement does not potentiate gonadotropin-releasing hormone agonist-induced androgen suppression in treatment of hirsutism. J Clin Endocrinol Metab 1994;79:447–451.
108.
Cunningham SK, Loughlin T, Culliton M, et al. Plasma sex hormone-binding globulin and androgen levels in the management of hirsute patients. Acta Endocrinol (Copenh) 1973;104:365–371.
109.
Gal M, Orly J, Barr I, et al. Low dose ketoconazole attenuates serum androgen levels in patients with polycystic ovary syndrome and inhibits ovarian steroidogenesis in vitro. Fertil Steril 1994;61:823– 832.
110.
Menard RH, Guenthner TM, Kon H, et al. Studies on the destruction of adrenal and testicular cytochrome P-450 by spironolactone. Requirement for the 7alpha-thio group and evidence for the loss of the heme and apoproteins of cytochrome P-450. J Biol Chem 1979;254:1726–1733.
111.
Cumming DC, Yang JC, Rebar RW, et al. Treatment of hirsutism with spironolactone. JAMA 1982;247:1295–1298.
112.